References
- Chesley L. Chesley's Hypertensive Disorders in Pregnancy, 2nd Ed., M. D. Lindheimer, J. M. Roberts, F. G. Cunningham. Appleton & Lange, Stamford, CT 1999
- Roberts J. M., et al. Preeclampsia: An Endothelial Cell Disorder. Am. J. Obstet. Gynecol. 1989; 161: 1200–1204
- Roberts J. M. Endothelial Dysfunction in Preeclampsia. Semin. Reprod. Endocrinol. 1998; 16(1)5–15
- Graham I. M., et al. Plasma Homocysteine as a Risk Factor for Vascular Disease: The European Concerted Action Project. JAMA 1997; 277: 1775–1781
- Mayer E. L., Jacobsen D. W., Robinson K. Homocysteine and Coronary Atherosclerosis. J. Am. Coll. Cardiol. 1996; 27: 517–527
- Stampfer M. J., et al. A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians. JAMA 1992; 268: 877–881
- Voutilainen S., et al. Enhanced In Vivo Lipid Peroxidation at Elevated Plasma Total Homocysteine Levels. Arterioscler. Thromb. & Vase. Biol. 1999; 19(5)1263–1266
- Kanani P. M., et al. Role of Oxidant Stress in Endothelial Dysfunction Produced by Experimental Hyperhomocyst(e)inemia in Humans. Circulation 1999; 100(11)1161–1168
- Upchurch G. R., Welch G. N., Loscalzo J. Homocysteine, EDRF and Endothelial Function. J. Nutr. 1996; 126: 1290S–1294S
- Powers R. W., et al. Plasma homocysteine Is Increased in Preeclampsia and Is Associated with Evidence of Endothelial Activation. Am. J. Obstet. Gynecol. 1998; 179: 1605–1611
- Dekker G. A., et al. Underlying Disorders Associated with Severe Early-Onset Preeclampsia. Am. J. Obstet. Gynecol. 1995; 173: 1042–1048
- Rajkovic A., Catalano P. M., Malinow M. R. Elevated Homocyst(e)ine Levels with Preeclampsia. Obstet. Gynecol. 1997; 90: 168–171
- Rajkovic A., et al. Plasma Homocyst(e)ine Concentrations in Eclamptic and Preeclamptic African Women Postpartum. Obstet. Gynecol. 1999; 94: 355–360
- Laivuori H., et al. Plasma Homocysteine Levels Elevated and Inversely Related to Insulin Sensitivity in Preeclampsia. Obstet. Gynecol. 1999; 93: 489–493
- Kosmehl H., Berndt A., Katenkamp D. Molecular Varients of Fibronectin and Laminin: Structure, Physiological Occurrence and Histopathological Aspects. Virchows Arch. 1996; 429: 311–322
- Ulrich M. M., et al. Increased Expression of Fibronectin Isoforms After Myocardial Infarction in Rats. J. Mol. Cell. Cardiol. 1997; 29: 2533–2543
- Sabri A., et al. Fibronectin Expression in the Cardiovascular System. Herz 1995; 2: 118–126
- Peters J., et al. Elevated Plasma Levels of ED1+ (“cellular”) Fibronectin in Patients with Vascular Injury. J. Lab. Clin. Med. 1989; 113(5)586–597
- Roberts J. M., Redman C. W. Pre-eclampsia: More Than Pregnancy-Induced Hypertension. Lancet 1993; 341: 1447–1451
- Sorensen T. K., et al. Elevated Second-Trimester Serum Homocysteine Levels and Subsequent Risk of Preeclampsia. Gynecol. Obstet. Invest. 1999; 48: 98–103
- Lentz S. R., et al. Vascular Dysfunction in Monkeys with Diet-Induced Hyperhomocysteinemia. J. Clin. Invest. 1996; 98: 24–29
- Bellamy M. F., et al. Hyperhomocysteinemia After an Oral Methionine Load Acutely Impairs Endothelial Function in Healthy Adults. Circulation 1998; 98(18)1848–1852
- Welch G. N., Upchurch G. R., Loscalzo J. Homocysteine, Oxidative Stress, and Vascular Disease. Hosp. Pract. 1997; 32: 81–92
- Majors A., Ehrhart A., Pezacka E. H. Homocysteine as a Risk Factor for Vascular Disease, Enhanced Collagen Proliferation and Accumulation by Smooth Muscle Cells. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2074–2081